Profile of Patients at a State-Run Tertiary Cancer Hospital in India: An Audit

Yıl 2019, Cilt: 5 Sayı: 3, 194 - 201, 01.07.2019

Meena Tiwari

https://doi.org/10.5455/umj.20190810072052

Öz

Background: Decreased cancer survival in developing countries is attribute to advanced stage at diagnosis, limited access to cancer care and unaffordability of treatment. Government of National Capital Territory NCT of Delhi set up a tertiary level cancer centre in the capital of India where world class tertiary level care is offered no cost. The present study was undertaken to assess the patient demographics of the hospital and descriptive statistics evaluated to arrive at better measures for patient treatment. Materials and methods: This is a retrospective study of all the patients registered in the Hospital in 2014. Information on socio demographic, diagnosis, dietary details at the time of registration followed by clinical extent of the disease and stage was analysed. Results: A total of 6900 patients registered at the hospital in 2014. 3687 patients were found to be eligible to be included in the study. The highest number of cancer cases seen in the adult age group of 21-65 years 2717; 70% . Carcinoma breast in females 424; 11% followed by carcinoma cervix 235; 6.4% and in males. Head and neck cancers 928; 84% followed by carcinoma lung 226; 82% were common. Most common metastatic cancer at presentation was hepatobiliary 182; 64% followed by lung 173; 63% . Conclusion: 21-65 years was the most common age group for all cancers with breast cancer in females and head neck cancers in males being the commonest cancers. Hepatobiliary and lung cancers behave aggressively and are frequently metastatic at presentation in Delhi and Northern India.

Anahtar Kelimeler

Cancer, audit, India, breast, cervix, lung

Kaynakça

• 1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer, 2013. Available from: http://globocan. iarc.fr
• 2. Pramesh CS, Badwe RA, Sinha RK. The National Cancer Grid of India. Indian J Med Paediatr Oncol. v.35(3); Jul-Sep 2014
• 3. Mohfw.gov.in [Internet]. India: Ministry of Health and Family Welfare; c2019 [cited 2019 July 4]. Available from: https:// mohfw.gov.in/sites/default/files/1493693747note_0.pdf
• 4. Dsci.nic.in [Internet]. India: Delhi State cancer institutes; c2019 [cited 2019 July 4]. Available from: http://www.dsci. nic.in/home.html
• 5. Mallath MK, Taylor DG, Badwe RA. The growing burden of cancer in India: epidemiology and social context. Cancer burden and health systems in India 1. Lancet Oncol 2014; 15: e205–12
• 6. Who.int [Internet]. Geneva: World Health Organization, International; c2019 [cited 2019 Aug 7]. Available from: https://www.who.int/classifications/icd/ICD10Volume2_en_2 010.pdf
• 7. Cancerindia.org [Internet]. India: Cancer India; c2019 [cited 2019 Aug 7]. Available from: http://cancerindia.org.in/uttarpradesh.html
• 8. WHO (2010): Health situation in the South East Asia Region 1994-1997, Regional office of SEAR, New Delhi. Available from:http://www.searo.who.int/india/topics/cancer/Cancer_f act_sheet.pdf
• 9. Ali I, Wani WA, Saleem K. Cancer Scenario in India with Future Perspectives. Cancer Therapy Vol 8, 56-70
• 10. Gupta A, Sridhar K, Dhillon PK. A review of breast cancer awareness among women in India: Cancer literate or awareness deficit? Eur J Cancer. 2015 Sep; 51(14): 2058– 2066
• 11. Malhotra RK, Manoharan N, Shukla NK, Rath GK. Gallbladder cancer incidence in Delhi urban: A 25-year trend analysis. Indian J Cancer. 2017;54:673-7
• 12. Unisa S, Jagannath P, Dhir V et. al. Population-based study to estimate prevalence and determine risk factors of gallbladder diseases in the rural Gangetic basin of North India. HPB (Oxford). 2011 Feb;13(2):117-25
• 13. Basu B, Sirohi B, Corrie P. Systemic therapy for neuro endocrine tumours of gastroenteropancreatic origin. Endocr Relat Cancer. 2010;17(1):R75–90
• 14. Bray F, Ferlay J, Soerjomataram I, Seigel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Ca Cancer J Clin 2018;68:394–424